5-substituted 2',3'-dideoxycytidine analogues have been synthesized and evaluated in vitro for their capabilities to protect t4+ lymphocytes from the cytopathic effects of the htlv-iii/lav ( hiv ) virus , the causative agent of acquired immunodeficiency syndrome ( aids ) .
C0012132
dideoxycytidine
C0001175
acquired immunodeficiency syndrome